Literature DB >> 25550318

Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection.

James L Harrison1, Bernard D Prendergast2, Jonathan A T Sandoe3.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25550318     DOI: 10.1136/heartjnl-2014-306873

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  11 in total

Review 1.  The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Authors:  J Ambrosioni; M Hernandez-Meneses; A Téllez; J Pericàs; C Falces; J M Tolosana; B Vidal; M Almela; E Quintana; J Llopis; A Moreno; José M Miro
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

Review 2.  [Hypersensitivity reactions to implantable cardiac pacemakers and defibrillators].

Authors:  B Kreft
Journal:  Hautarzt       Date:  2016-05       Impact factor: 0.751

3.  18F-FDG PET/CT now endorsed by guidelines across all types of CIED infection: Evidence limited but growing.

Authors:  Fozia Zahir Ahmed; Parthiban Arumugam
Journal:  J Nucl Cardiol       Date:  2017-11-29       Impact factor: 5.952

4.  Application of an Infection Control Protocol (ICP) Reduced Cardiac Device Infection (CDI) in Low-Volume Centers.

Authors:  Gongchang Guan; Zhongwei Liu; Yong Zhang; Fangyun Wang; Haiming Ji; Xuewen Li; Yuan Chen; Xiaoqiang Yang; Jianxia Wei; Kai Yu; Ming Zhang
Journal:  Med Sci Monit       Date:  2018-03-06

5.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

6.  Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy.

Authors:  Thomas Kleemann; Margit Strauss; Kleopatra Kouraki; Eleni Lampropoulou; Andràs Fendt; Nicolas Werner; Ralf Zahn
Journal:  Clin Cardiol       Date:  2019-07-17       Impact factor: 2.882

7.  Clostridioides (Clostridium) difficile Pacemaker Infection.

Authors:  Anna Berkefeld; Fabian K Berger; Barbara C Gärtner; Nina Wantia; Anatol Prinzing; Karl-Ludwig Laugwitz; Dirk H Busch; Kathrin Rothe
Journal:  Open Forum Infect Dis       Date:  2020-10-14       Impact factor: 3.835

8.  Quantitative and Qualitative Assessment of Adhesive Thrombo-Fibrotic Lead Encapsulations (TFLE) of Pacemaker and ICD Leads in Arrhythmia Patients-A Post Mortem Study.

Authors:  Jonas Keiler; Marko Schulze; Ronja Dreger; Armin Springer; Alper Öner; Andreas Wree
Journal:  Front Cardiovasc Med       Date:  2020-11-30

9.  Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures.

Authors:  Caio Marcos de Moraes Albertini; Katia Regina da Silva; Joaquim Maurício da Motta Leal Filho; Elizabeth Sartori Crevelari; Martino Martinelli Filho; Francisco Cesar Carnevale; Roberto Costa
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

10.  Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study.

Authors:  Fozia Zahir Ahmed; Catherine Fullwood; Mahvash Zaman; Ahmed Qamruddin; Colin Cunnington; Mamas A Mamas; Jonathan Sandoe; Manish Motwani; Amir Zaidi
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.